NZ Ministry of Health releases latest cancer death figures – prostate way up there

PROSTABLOG NZ: For NZ males, prostate cancer accounted for 28.6 percent of all cancer registrations in 2007, reports the NZ Ministry of Health, with the next-most-common registrations being colorectal cancer and malignant melanoma of the skin. READ MORE>

Read Full Post »

Science close to test for seriousness of prostate cancer diagnosis

WALL ST JOURNAL: Scientists may soon be able to answer the agonising question facing men with prostate cancer: does their cancer need immediate treatment or can it be left alone? READ MORE> and HERE> and HERE>

Read Full Post »

US urologists vary in their approach to prostate cancer

NEW PROSTATE CANCER INFOLINK: For all of the academic literature and the recommendations of guideline-generating organizations on testing, diagnosis, and management of prostate cancer, urologists out in community practice may show considerable variation in their clinical practice patterns. READ MORE>

Read Full Post »

Do statin drugs for cholesterol help prostate cancer patients, or not?

LA TIMES:  Two studies and a review of previous studies address the widely prescribed cholesterol drugs: one questions their use as a preventive measure; another suggests they help prostate cancer patients. READ MORE>

Read Full Post »

Prostate cancer is the most sensitive to hormones

URO TODAY: Of all cancers, prostate cancer is the most sensitive to hormones: it is thus very important to take advantage of this unique property and to always use optimal androgen blockade when hormone therapy is the appropriate treatment.  READ MORE>

Read Full Post »

Doctors failing to see depression risk from prostate cancer

ABC NEWS: Many doctors are failing to recognise the effects that breast and prostate cancer have on a patient’s mental health, according to a recent study. READ MORE>

Read Full Post »

Good prostate cancer news for drinkers of red wine and green tea

TORONTO SUN: Green tea and red wine are very effective at blocking prostate cancer’s growth, recent studies have shown. READ MORE>

Read Full Post »

Year-long wait for Provenge in US hospitals

BLOOMBERG: Prostate cancer patients seeking Dendreon Corp’s new tumour-fighting vaccine, Provenge, face delays of a year or more as hospital waiting lists dwarf the company’s capacity to produce medicine. READ MORE>

Read Full Post »

Most comprehensive genomic analysis of prostate cancer to date

SCIENCE CENTRIC: A unique collaboration among physician-scientists at Memorial Sloan-Kettering Cancer Centre has yielded the most comprehensive genomic analysis of prostate cancer to date. READ MORE>

Read Full Post »

What the American Cancer Society recommends about prostate cancer screening

URO TODAY: The American Cancer Society updated its recommendations on prostate cancer screening after a series of reviews. READ MORE> It says: Prostate cancer screening should not occur without an informed decision-making process. Men at average risk should receive this information beginning at age 50. Men in higher-risk groups should receive this information before age [...]

Read Full Post »